Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Jazz Pharmaceuticals
Biotech
Jazz puts up $771M to form Autifony neuroscience discovery pact
GSK spinout Autifony has secured up to $770.5 million to discover drug candidates against ion channel targets associated with neurological disorders.
Nick Paul Taylor
Nov 14, 2023 9:40am
Madrigal snags Sanofi exec as CEO—Chutes & Ladders
Sep 15, 2023 9:30am
Jazz auditioning for new bandmates in hot M&A market
Jun 6, 2023 9:35am
Zymeworks links HER2 bispecific to 84% survival at 18 months
Jan 19, 2023 9:55am
Jazz hands Zymeworks a much-needed win after peek at data
Dec 21, 2022 10:02am
Jazz pays $50M for Zymeworks' phase 3 HER2-directed bispecific
Oct 19, 2022 8:30am
